ES2053777T3 - Compuestos. - Google Patents

Compuestos.

Info

Publication number
ES2053777T3
ES2053777T3 ES88312111T ES88312111T ES2053777T3 ES 2053777 T3 ES2053777 T3 ES 2053777T3 ES 88312111 T ES88312111 T ES 88312111T ES 88312111 T ES88312111 T ES 88312111T ES 2053777 T3 ES2053777 T3 ES 2053777T3
Authority
ES
Spain
Prior art keywords
molar
polymer
preparation
units
rondan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88312111T
Other languages
English (en)
Inventor
Albert Andrzej Jaxa-Chamiec
Deirdre Mary Bernadette Hickey
Brian Peter Slingsby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of ES2053777T3 publication Critical patent/ES2053777T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Graft Or Block Polymers (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

POLIMEROS DE LA ESTRUCTURA(I) EN LA CUAL R1 ES UN GRUPO ALQUILO C6 C20 SATURADO O INSATURADO; R2 Y R3 SON IGAULES O DIFERENTES Y CADA UNO ALQUILO C1; X- ES UN CONTRA - ION ACEPTABLE FISIOLOGICAMENTE; A, B, C SON NUMEROS QUE INDIUCAN % MOLARES RELATIVOS DE LAS UNIDADES PRESENTES EN UNA DISTRIBUCION RONDAN EN DICHO POLIMERO, (B) ES DE 0.5 A 10% MOLAR, Y (C) ES DE 30 A 99% MOLAR; Y N ES UN NUMERO QUE INDICA LAS UNIDADES DE REPETICION EN DICHO POLIMERO, PROCESOS PARA LA PREPARACION, INTERMEDIARIOS UTILES EN SU PREPARACION, COMPUESTOS FARMACEUTICOS QUE LOS CONTIENEN Y SU USO EN LA TERAPIA PARA BAJAR LOS NIVELES DE COLESTEROL EN PLASMA EN HUMANOS.
ES88312111T 1987-12-23 1988-12-21 Compuestos. Expired - Lifetime ES2053777T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878730010A GB8730010D0 (en) 1987-12-23 1987-12-23 Compounds

Publications (1)

Publication Number Publication Date
ES2053777T3 true ES2053777T3 (es) 1994-08-01

Family

ID=10628957

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88312111T Expired - Lifetime ES2053777T3 (es) 1987-12-23 1988-12-21 Compuestos.

Country Status (19)

Country Link
US (1) US4954339A (es)
EP (1) EP0322209B1 (es)
JP (1) JPH02502924A (es)
KR (1) KR900700512A (es)
CN (1) CN1034550A (es)
AT (1) ATE85624T1 (es)
AU (1) AU2921789A (es)
DE (1) DE3878431T2 (es)
DK (1) DK411589D0 (es)
ES (1) ES2053777T3 (es)
FI (1) FI893924L (es)
GB (1) GB8730010D0 (es)
HU (1) HUT54716A (es)
IL (1) IL88696A (es)
NZ (1) NZ227386A (es)
PT (1) PT89338B (es)
WO (1) WO1989005828A1 (es)
ZA (1) ZA889521B (es)
ZW (1) ZW17988A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913823D0 (en) * 1989-06-15 1989-08-02 Smith Kline French Lab Compounds
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
EP1800686A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
JP2007023075A (ja) * 2005-07-12 2007-02-01 Fujifilm Holdings Corp 有機変性層状珪酸塩を含有するポリエステル樹脂組成物
WO2010093398A1 (en) * 2009-02-13 2010-08-19 Dow Global Technologies Inc. Amination of vinyl aromatic polymers with tertiary amines
ES2888231T3 (es) * 2010-09-20 2022-01-03 Sirna Therapeutics Inc Lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos
WO2015049839A1 (ja) * 2013-10-01 2015-04-09 日東電工株式会社 アニオン交換樹脂を溶媒に溶解させたアイオノマー溶液

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL73179C (es) * 1947-07-05
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
BE580490A (fr) * 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
NL7017227A (es) * 1969-12-27 1971-06-29
US3898088A (en) * 1973-09-26 1975-08-05 Eastman Kodak Co Photographic elements containing polymeric mordants
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
IT1097396B (it) * 1978-07-24 1985-08-31 Texcontor Ets Resine scambiatrici di ioni del tipo anionico con proprieta' ipocolesterolemizzanti
US4532128A (en) * 1981-09-15 1985-07-30 Dynapol Quaternary ammonium group-containing polymers having antimicrobial activity
WO1983001002A1 (en) * 1981-09-15 1983-03-31 Dynapol Shareholders Liquidati Quaternary ammonium group-containing polymers having antimicrobial activity
US4482680A (en) * 1981-09-15 1984-11-13 Dynapol Quaternary ammonium group-containing polymers having antimicrobial activity
CH655507B (es) * 1983-01-12 1986-04-30

Also Published As

Publication number Publication date
IL88696A (en) 1992-07-15
ATE85624T1 (de) 1993-02-15
PT89338B (pt) 1993-08-31
FI893924A7 (fi) 1989-08-21
DE3878431D1 (de) 1993-03-25
JPH02502924A (ja) 1990-09-13
WO1989005828A1 (en) 1989-06-29
FI893924A0 (fi) 1989-08-21
HUT54716A (en) 1991-03-28
HU890676D0 (en) 1991-01-28
GB8730010D0 (en) 1988-02-03
NZ227386A (en) 1991-07-26
KR900700512A (ko) 1990-08-13
AU2921789A (en) 1989-07-19
CN1034550A (zh) 1989-08-09
DE3878431T2 (de) 1993-07-22
DK411589A (da) 1989-08-22
FI893924L (fi) 1989-08-21
US4954339A (en) 1990-09-04
ZA889521B (en) 1990-08-29
EP0322209B1 (en) 1993-02-10
EP0322209A1 (en) 1989-06-28
ZW17988A1 (en) 1989-07-19
DK411589D0 (da) 1989-08-22
PT89338A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
ES2087061T3 (es) Utilizacion de ribosido o ribotido de aica para la fabricacion de un medicamento contra la crisis cardiaca o el infarto de miocardio en los pacientes que sufren de ateroesclerosis.
ES2059377T3 (es) Pirazoles 1,5-diaril-3-sustituidos farmacologicamente activos y procedimiento para sintetizar los mismos.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE9695T1 (de) Antihistamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT87261A (pt) Processo de preparacao de heparinas de baixo peso molecular,com estrutura regular e de composicoes farmaceuticas que as contem
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
MX9207394A (es) Esteroides de 17-espirofuran-3'-ilideno.
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
DE69020797D1 (de) Lösung von hochmolekularen Polycarbodiimiden sowie Verfahren zu deren Herstellung.
ES2053777T3 (es) Compuestos.
NO893135D0 (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ES2060078T3 (es) Glicolipido vegetal positivo al ensayo de limulus y metodo de estimular el sistema inmunitario de un animal.
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
UA15930A (uk) Спосіб одержаhhя похідhих тієhопіраhу
ES2070202T3 (es) Nuevos derivados de serina, procedimiento para su preparacion y su uso en terapia humana.
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
MX174093B (es) 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
ES2063305T3 (es) Derivados de bifenilo, procedimiento para la preparacion de los mismos e intermedios para los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322209

Country of ref document: ES